Complementary or alternative medicine: The need for plausibility

CMAJ. Canadian Medical Association Journal

Volumn 168, Issue 2, 2003, Pages 180-182

  Hoffer, L John ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSAMINE SULFATE; HYPERICUM PERFORATUM EXTRACT; LEVODOPA;

ALTERNATIVE MEDICINE; CLINICAL RESEARCH; CLINICAL STUDY; DEPRESSION; EVALUATION; HOMEOPATHY; HUMAN; NOTE; OSTEOARTHRITIS; PARKINSON DISEASE; PRACTICE GUIDELINE; TREATMENT OUTCOME;

EID: 0037248894     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (23)

1. Antman K, Lagakos S, Drazen J. Designing and funding clinical trials of novel therapies. N Engl J Med 2001;344(10):762-3.
2. Spencer JW. Essential issues in complementary/alternative medicine. In: Spencer JW, Jacobs JJ, editors. Complementary/alternative medicine: an evidence-based approach. Mosby: St.Louis; 1999. p. 3-36.
3. O'Hara DP. Is there a role for prayer and spirituality in health care? Med Clin North Am 2002;86:33-46.
4. Ernst E. The role of complementary and alternative medicine in cancer. Lancet Oncol 2000;1:176-180.
5. Antman K, Benson MC, Chabot J, Cobrinik D, Grann VR, Jacobson JS, et al. Complementary and alternative medicine: the role of the cancer center. J Clin Oncol 2001;19:55S-60S.
6. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 1997;336:1117-24.
7. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, et al. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001;344:3-10.
8. Hrobjartsson A, Gøtzsche PC. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med 2001;344:1594-9.
9. Knowler WC, Barrett-Connor E, Fowler WE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
10. Hart A. Randomized controlled trials: the control group dilemma revisited. Complement Ther Med 2001;9:40-4.
11. Byar DP. Some statistical considerations for design of cancer prevention trials. Prev Med 1989;18(5):688-99.
12. Inouye SK, Bogardus ST Jr, Charpentier PA, Leo-Summers L, Acampora D, Holford TR, et al. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 1999;340:669-76.
13. Donohoe ME, Fletton JA, Hook A, Powell R, Robinson I, Stead JW, et al. Improving foot care for people with diabetes mellitus - a randomized controlled trial of an integrated care approach. Diabet Med 2000;17:581-7.
14. Walker AE, Campbell MK, Grimshaw JM. A recruitment strategy for cluster randomized trials in secondary care settings. J Eval Clin Pract 2000;6:185-92.
15. Gortmaker SL, Peterson K, Wiecha J, Sobol AM, Dixit S, Fox MK, et al. Reducing obesity via a school-based interdisciplinary intervention among youth: Planet Health. Arch Pediatr Adolesc Med 1999;153:409-18.
16. Hoffer LJ. Proof versus plausibility: rules of engagement for the struggle to evaluate alternative cancer therapies. CMAJ 2001;164(3):351-3.
17. Cotzias GC, Papavasiliou PS, Gellene R. Modification of Parkinsonism - chronic treatment with L-dopa. N Engl J Med 1969; 280(7):337-45.
18. Ioannidis JP, Haidich AB, Pappa M, Pantazis N, Kokori SI, Tektonidou MG, et al. Comparison of evidence of treatment effects in randomized and nonrandomized studies. JAMA 2001;286:821-30.
19. Lukoff D, Edwards D, Miller M. The case study as a scientific method for researching alternative therapies. Altern Ther Health Med 1998;4:44-52.
20. Vanchieri C. Alternative therapies getting notice through Best Case Series Program. J Natl Cancer Inst 2000;92:1558-60.
21. Guyatt G, Sackett D, Taylor DW, Chong J, Roberts R, Pugsley S. Determining optimal therapy - randomized trials in individual patients. N Engl J Med 1986;314(14):889-92.
22. Guyatt G, Sackett D, Adachi J, Roberts R, Chong J, Rosenbloom D, et al. A clinician's guide for conducting randomized trials in individual patients. CMAJ 1988;139:497-503.
23. White A, Ernst E. The case for uncontrolled clinical trials: a starting point for the evidence base for CAM. Complement Ther Med 2001;9:111-6.